About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Binaural Sound for Remimazolam Induction | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT06099977

Binaural Sound for Remimazolam Induction

It is important to decrease the time-to-loss of consciousness and anesthetics dose of remimazolam for general anesthesia induction. We will evaluate the effect of binaural sound for general anestheia ...

Lead sponsor: Gangnam Severance Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Hyun-Chang Kim

CONTACT

82-2-2224-3919 [email protected]

Sponsors

Lead Sponsor

Gangnam Severance Hospital

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Patients scheduled for generla anesthesia
•2. Patients aged 20-60
•3. Patients with American Society of Anesthesiologist physical status classification 1-2
•4. Patients with ideal body weight 50-80 kg

Exclusion Criteria

•1. Patients with hearing disability
•2. Patients using opioids or sedatives in 1 week
•3. Patients who are dependent for alcoholics or drugs
•4. Patients with hypersensitivities to remimazolam
•5. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
•6. Patients with liver failure

Related studies

Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)

NCT07580196 · Prostate Cancer

Selecting Hypoxic Tumours for Treatment Modification

NCT06787053 · Bladder (Urothelial, Transitional Cell) Cancer, Prostate Cancer

RECRUITINGPhase 1/2

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer

NCT07181122 · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 18, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment72

Start dateNov 2023

Last updatedNov 18, 2023

Condition

General Anesthesia Prostate Cancer Uterine Myoma

Locations shown

GangnamSeveranceHospital

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions